Author:
Weaver Michael F.,Schnoll Sidney H.
Reference50 articles.
1. Abraham HD, Aldridge AM, Gogia P (1996) The psychopharmacology of hallucinogens. Neuro-psychopharmacology 14:285–298
2. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn, text revision. American Psychiatric Publishing, Arlington, VA
3. Anis NA, Berry SC, Burton, N, et al (1983) The dissociative anesthetics ketamine and phencyclidine selectively reduce excitation of central mammalian neurons by N-methyl-D-aspartate. Br J Pharmacol 79:565–575
4. Bowyer JF, Spuhler KP, Weiner N (1984) Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes. J Pharmacol Exp Ther 229:671–680
5. Bryant WK, Ompad DC, Ahern J, et al (2006) Period and birth-cohort effects on age of first phencyclidine (PCP) use among drug users in New York City, 1960–2000. Ann Epidemiol 16:266–272